Could Medicare beneficiaries see a decrease in Medicare premiums?

The Health and Human Services Secretary Xavier Becerra said: the overestimate in costs of covering an expensive and controversial new Alzheimer’s drug will result in a Medicare premium adjustment. However, it will not happen this year or how much of an adjustment it will be. Since the drug manufacturer has cut the cost of the drug in half, and the limitations on coverage by Medicare, CMS could pass the savings on to Medicare beneficiaries. Read the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org